Loading...
 

Volume 30, Issue 2, June 2019






Sign in to download the Issue in PDF format.

 

Mediterr J Rheumatol 2019;30(2):125-34
Objective measurement of sedentary time and physical activity in people with rheumatoid arthritis: protocol for an accelerometer and activPALμTM validation study
Authors Information

1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom

2Department of Rheumatology, Russells Hall Hospital, Dudley Group NHS Foundation Trust, West Midlands, United Kingdom

3Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, United Kingdom

Abstract

 

Background: The accurate measurement of sedentary time and physical activity in Rheumatoid Arthritis (RA) is critical to identify important health consequences and determinants of these behaviours in this patient group. However, objective methods have not been well-validated for measurement of sedentary time and physical activity in RA. Aims: Specific objectives are to: 1) validate the ActiGraph GT3X+ accelerometer and activPAL3mTM against indirect calorimetry and direct observation respectively, and define RA-specific accelerometer cut-points, for measurement of sedentary time and physical activity in RA; 2) validate the RA-specific sedentary time accelerometer cut-points against the activPAL3mTM; 3) compare sedentary time and physical activity estimates in RA, using RA-specific vs. widely-used non-RA accelerometer cut-points. Methods: Objective 1: People with RA will wear an ActiGraph GT3X+, activPAL3mTM, heart rate monitor and indirect calorimeter, whilst being video-recorded undertaking 11 activities representative of sedentary behaviour, and light and moderate intensity physical activity. Objectives 2 and 3: People with RA will wear an ActiGraph GT3X+ and activPAL3mTM for 7 days to measure free-living sedentary time and physical activity. Discussion: This will be the first study to define RA-specific accelerometer cut-points, and represents the first validation of the ActiGraph accelerometer and activPALTM, for measurement of sedentary time and physical activity in RA. Findings will inform future RA studies employing these devices, ensuring more valid assessment of sedentary time and physical activity in this patient group.